This week, In Good Company with Nicolai Tangen focused on pharmaceutical innovation and leadership, featuring Pfizer CEO Albert Bourla discussing the company's approach to drug discovery and his perspectives on global markets. The episodes explored how major pharmaceutical leaders navigate complex challenges ranging from scientific breakthroughs to geopolitical considerations, offering insight into the mindset required to lead transformative organizations in healthcare.
Episodes This Week
Get a free sample digest — no signup needed
Real AI summaries from top in good company with nicolai tangen podcasts, straight to your inbox.
No spam, unsubscribe anytime. We'll send one sample digest, then you decide.
Other Weeks
This Week in In Good Company with Nicolai Tangen (May 11 - May 17, 2026)
2 episodes · May 11 – May 17
This Week in In Good Company with Nicolai Tangen (May 4 - May 10, 2026)
2 episodes · May 4 – May 10
This Week in In Good Company with Nicolai Tangen (Apr 27 - May 3, 2026)
2 episodes · Apr 27 – May 3
This Week in In Good Company with Nicolai Tangen (Apr 20 - Apr 26, 2026)
2 episodes · Apr 20 – Apr 26
This Week in In Good Company with Nicolai Tangen (Apr 13 - Apr 19, 2026)
2 episodes · Apr 13 – Apr 19
This Week in In Good Company with Nicolai Tangen (Apr 6 - Apr 12, 2026)
2 episodes · Apr 6 – Apr 12
This Week in In Good Company with Nicolai Tangen (Mar 30 - Apr 5, 2026)
2 episodes · Mar 30 – Apr 5
This Week in In Good Company with Nicolai Tangen (Mar 23 - Mar 29, 2026)
3 episodes · Mar 23 – Mar 29